• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens.

作者信息

Andrews J M, Wise R

机构信息

Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.

出版信息

J Antimicrob Chemother. 1994 Apr;33(4):849-53. doi: 10.1093/jac/33.4.849.

DOI:10.1093/jac/33.4.849
PMID:8056704
Abstract
摘要

相似文献

1
The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens.
J Antimicrob Chemother. 1994 Apr;33(4):849-53. doi: 10.1093/jac/33.4.849.
2
In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci.新型半合成注射用普那霉素RP 59500对葡萄球菌的体外活性
Zentralbl Bakteriol. 1996 Apr;283(4):497-501. doi: 10.1016/s0934-8840(96)80127-7.
3
Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.新型胃肠外注射半合成链阳菌素RP 59500对具有多种对大环内酯-林可酰胺-链阳菌素类抗生素耐药机制的葡萄球菌的活性。
J Antimicrob Chemother. 1992 Jul;30 Suppl A:67-75. doi: 10.1093/jac/30.suppl_a.67.
4
In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods.采用两种方法对新型链阳菌素RP 59500进行体外抗葡萄球菌活性及测试。
Antimicrob Agents Chemother. 1992 Apr;36(4):854-5. doi: 10.1128/AAC.36.4.854.
5
[Sensitivity to staphylomycin of the bacterial flora isolated from expectorate in the course of various bronchopneumopathies].
G Ital Chemioter. 1967 Jan-Dec;14(1):70-4.
6
In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
J Antimicrob Chemother. 1992 Jul;30 Suppl A:15-8. doi: 10.1093/jac/30.suppl_a.15.
7
In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.
J Antimicrob Chemother. 1992 Jul;30 Suppl A:59-65. doi: 10.1093/jac/30.suppl_a.59.
8
Recent developments in streptogramin research.链阳菌素研究的最新进展。
Curr Pharm Des. 1998 Apr;4(2):155-80.
9
In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
J Antimicrob Chemother. 1992 Jul;30 Suppl A:77-81. doi: 10.1093/jac/30.suppl_a.77.
10
[In vitro activity of pristinamycin on respiratory bacteria].
Presse Med. 1999 Sep 4;28 Suppl 1:6-9.

引用本文的文献

1
Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.奎奴普丁/达福普汀：用于治疗严重革兰氏阳性菌感染的综述
Drugs. 1999 Dec;58(6):1061-97. doi: 10.2165/00003495-199958060-00008.
2
Antibiotic resistance: a current perspective.抗生素耐药性：当前视角
Br J Clin Pharmacol. 1999 Aug;48(2):109-24. doi: 10.1046/j.1365-2125.1999.00997.x.
3
Learning to live with MRSA.学会与耐甲氧西林金黄色葡萄球菌共存。
Postgrad Med J. 1998 Jul;74(873):385-6. doi: 10.1136/pgmj.74.873.385.
4
In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae.喹奴普丁-达福普汀及链阳性菌素RPR 106972对肺炎支原体的体外活性
Antimicrob Agents Chemother. 1998 Mar;42(3):698-9. doi: 10.1128/AAC.42.3.698.
5
Quinupristin-dalfopristin.奎奴普丁-达福普汀
Drugs. 1996 Sep;52(3):406-15. doi: 10.2165/00003495-199652030-00006.
6
Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.奎奴普丁/达福普汀的抗菌活性。临床应用原理。
Drugs. 1996;51 Suppl 1:31-7. doi: 10.2165/00003495-199600511-00007.